Search results
30 lip 2024 · In their study, recently published in Nature, the researchers found that treatment with the anti-IL-11 drug from 75 weeks of age until death extended the median lifespan of male mice by 22.5% and of female mice by 25%.
17 lip 2024 · The results, published in Nature, were dramatic, with mice given the anti-IL-11 drug from 75 weeks of age until death having their median lifespan extended by 22.4% in males and 25% in...
18 lip 2024 · Anti-IL-11 therapy boosted metabolism, with the animals producing calorie-burning brown fat, not problematic stores of white fat, blocked the loss of muscle mass and strength, and protected...
17 lip 2024 · The results, published in Nature, were dramatic, with mice given the anti-I-11 drug from 75 weeks of age until death having their median lifespan extended by 22.4% in males and 25% in females . The mice lived for an average of 155 weeks, compared with 120 weeks in untreated mice.
17 lip 2024 · Unlike other drugs known to inhibit specific pathways involved in aging, such as metformin and rapamycin, anti-IL-11 therapy blocks multiple major signaling mechanisms that become...
17 lip 2024 · Heidi Ledford. Laboratory mice live longer when they have an immune protein called IL-11 blocked, a study has found. Credit: Panther Media GmbH/Alamy. A protein that promotes inflammation...
interleukin-11 (IL-11) actively promotes aging and that giving an anti- IL-11 therapy not only counteracts the deleterious effects of aging but also increases lifespan.
